{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:59:17Z","timestamp":1784743157620,"version":"3.55.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01566-3","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:34:12Z","timestamp":1759484052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Flufenamic acid-based sulfonohydrazide and acetamide derivatives NSAI as inhibitors of multi-targets COX-1\/COX-2\/5-LOX: design, synthesis, in\u00a0silico ADMET and binding mode studies"],"prefix":"10.1186","volume":"19","author":[{"given":"Shaimaa","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa S.","family":"Abusaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousry A.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"El-Sayed Mansou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arafa","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triveena M.","family":"Ramsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"1","key":"1566_CR1","first-page":"495","volume":"8","author":"Y Ammar","year":"2016","unstructured":"Ammar Y, Fayed E, Bayoumi A, Saleh M. Synthesis and biological evaluation of new amides pro-drugs containing naproxen moiety as anti-inflammatory and antimicrobial agents. Der Pharma Chemica. 2016;8(1):495\u2013508.","journal-title":"Der Pharma Chemica"},{"key":"1566_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104742","volume":"109","author":"EA Fayed","year":"2021","unstructured":"Fayed EA, Bayoumi AH, Saleh AS, Ezz Al-Arab EM, Ammar YA. In vivo and in vitro anti-inflammatory, antipyretic and ulcerogenic activities of pyridone and chromenopyridone derivatives, physicochemical and pharmacokinetic studies. Bioorg Chem. 2021;109: 104742.","journal-title":"Bioorg Chem"},{"key":"1566_CR3","first-page":"245","volume":"5","author":"YA Ammar","year":"2015","unstructured":"Ammar YA, Fayed EA, Bayoumi AH, Saleh MA, El-Araby ME. Design and synthesis of pyridine-amide based compounds appended naproxen moiety as anti-microbial and anti-inflammatory agents. Am J PharmTech Res. 2015;5:245\u201373.","journal-title":"Am J PharmTech Res"},{"key":"1566_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.132839","volume":"1260","author":"EA Fayed","year":"2022","unstructured":"Fayed EA, Al-Arab EME, Saleh AS, Bayoumi AH, Ammar YA. Design, synthesis, in silico studies, in vivo and in vitro assessment of pyridones and thiazolidinones as anti-inflammatory, antipyretic and ulcerogenic hits. J Mol Struct. 2022;1260: 132839.","journal-title":"J Mol Struct"},{"issue":"12","key":"1566_CR5","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822\u201332.","journal-title":"Nat Med"},{"issue":"2","key":"1566_CR6","first-page":"522","volume":"7","author":"DH Mohamed","year":"2023","unstructured":"Mohamed DH, Mantawy EM, Said RS, Kassem DH, Gad AM, El-Demerdash ZE. Radiation-induced premature ovarian failure: focus on the role of ovarian inflammatory signaling pathways. Arch Pharm Sci Ain Shams Univ. 2023;7(2):522\u201338.","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"1566_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.bioeng.8.061505.095708","volume":"8","author":"GW Schmid-Sch\u00f6nbein","year":"2006","unstructured":"Schmid-Sch\u00f6nbein GW. Analysis of inflammation. Annu Rev Biomed Eng. 2006;8:93\u2013151.","journal-title":"Annu Rev Biomed Eng"},{"issue":"33","key":"1566_CR8","doi-asserted-by":"publisher","first-page":"24287","DOI":"10.1039\/D4RA03865G","volume":"14","author":"T Ramsis","year":"2024","unstructured":"Ramsis T, Refat M, Selim HM, Elseedy H, Fayed EA. The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne. RSC Adv. 2024;14(33):24287\u2013321.","journal-title":"RSC Adv"},{"key":"1566_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-031-29231-6_2","volume-title":"Neuroimmune interactions in pain: mechanisms and therapeutics","author":"J Ji","year":"2023","unstructured":"Ji J, Yuan M, Ji R-R. Inflammation and pain. In: Ji R-R, Cheng J, Ji J, editors. Neuroimmune interactions in pain: mechanisms and therapeutics. Cham: Springer International Publishing; 2023. p. 17\u201341."},{"issue":"6","key":"1566_CR10","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1007\/s10787-024-01527-7","volume":"32","author":"OA Younes","year":"2024","unstructured":"Younes OA, Elsherbiny DM, Hanna DMF, Gad AM, Azab SS. Tocilizumab unfolds colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling. Inflammopharmacology. 2024;32(6):3881\u201398.","journal-title":"Inflammopharmacology"},{"issue":"7S_Part_10","key":"1566_CR11","doi-asserted-by":"publisher","first-page":"P527","DOI":"10.1016\/j.jalz.2017.06.622","volume":"13","author":"AA Ali","year":"2017","unstructured":"Ali AA, El Shaer SS, Gad AM, Abu-Elfotuh K. [P1\u2013606]: impact of physical and mental activities versus protein malnutrition associated with social isolation during induction and progression of Alzheimer\u2019s disease in rats. Alzheimer\u2019s Dementia. 2017;13(7S_Part_10):P527\u20138.","journal-title":"Alzheimer\u2019s Dementia."},{"key":"1566_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejphar.2016.08.033","volume":"791","author":"AF Cidade","year":"2016","unstructured":"Cidade AF, Vasconcelos PA, Silva DPB, Florentino IF, Vasconcelos GA, Vaz BG, et al. Design, synthesis and pharmacological evaluation of new anti-inflammatory compounds. Eur J Pharmacol. 2016;791:195\u2013204.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1566_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/10408360091174286","volume":"37","author":"E Fosslien","year":"2000","unstructured":"Fosslien E. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci. 2000;37(5):431\u2013502.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"1566_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.1996.tb00144.x","volume":"10","author":"M Pairet","year":"1996","unstructured":"Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol. 1996;10(1):1\u201315.","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"1566_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","volume":"154","author":"I Bjarnason","year":"2018","unstructured":"Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154(3):500\u201314.","journal-title":"Gastroenterology"},{"key":"1566_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114147","volume":"180","author":"S Bindu","year":"2020","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180: 114147.","journal-title":"Biochem Pharmacol"},{"key":"1566_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejmech.2015.05.001","volume":"98","author":"S Shenvi","year":"2015","unstructured":"Shenvi S, Kiran KR, Kumar K, Diwakar L, Reddy GC. Synthesis and biological evaluation of boswellic acid-NSAID hybrid molecules as anti-inflammatory and anti-arthritic agents. Eur J Med Chem. 2015;98:170\u20138.","journal-title":"Eur J Med Chem"},{"issue":"11","key":"1566_CR18","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.bmcl.2009.04.059","volume":"19","author":"KRA Abdellatif","year":"2009","unstructured":"Abdellatif KRA, Chowdhury MA, Dong Y, Das D, Yu G, Vel\u00e1zquez CA, et al. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies. Bioorg Med Chem Lett. 2009;19(11):3014\u20138.","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"1566_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-121-9-199411010-00010","volume":"121","author":"WR Henderson","year":"1994","unstructured":"Henderson WR. The role of leukotrienes in inflammation. Ann Intern Med. 1994;121(9):684\u201397.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1566_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/187221313804004682","volume":"7","author":"SR Naik","year":"2013","unstructured":"Naik SR, Wala SM. Inflammation, allergy and asthma, complex immune origin diseases: mechanisms and therapeutic agents. Recent Patents Inflamm Allergy Drug Discov. 2013;7(1):62\u201395.","journal-title":"Recent Patents Inflamm Allergy Drug Discov."},{"issue":"3","key":"1566_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/157340805774580466","volume":"1","author":"E Pontiki","year":"2005","unstructured":"Pontiki E, Hadjipavlou-Litina D. Lipoxygenases (LOs): an heterogenous family of lipid peroxidizing enzymes implicated in cell differentiation, inflammation, asthma, carcinogenesis, atherogenesis-an interesting target for the development of promising drugs. Curr Enzym Inhib. 2005;1(3):309\u201327.","journal-title":"Curr Enzym Inhib"},{"issue":"3","key":"1566_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/molecules23030685","volume":"23","author":"K Liaras","year":"2018","unstructured":"Liaras K, Fesatidou M, Geronikaki A. Thiazoles and thiazolidinones as COX\/LOX inhibitors. Molecules. 2018;23(3):685.","journal-title":"Molecules"},{"issue":"7","key":"1566_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1517\/13543776.2013.791678","volume":"23","author":"B Hofmann","year":"2013","unstructured":"Hofmann B, Steinhilber D. 5-Lipoxygenase inhibitors: a review of recent patents (2010\u20132012). Expert Opin Ther Pat. 2013;23(7):895\u2013909.","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"1566_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1039\/C7MD00390K","volume":"9","author":"C Hu","year":"2018","unstructured":"Hu C, Ma S. Recent development of lipoxygenase inhibitors as anti-inflammatory agents. MedChemComm. 2018;9(2):212\u201325.","journal-title":"MedChemComm"},{"issue":"2","key":"1566_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00044-022-02995-8","volume":"32","author":"L Du","year":"2023","unstructured":"Du L, Du S, Li J, Wang H. Design, synthesis, and biological evaluation of dual-target COX-2\/5-LOX inhibitors for the treatment of inflammation. Med Chem Res. 2023;32(2):218\u201338.","journal-title":"Med Chem Res"},{"key":"1566_CR26","first-page":"77","volume":"8","author":"E Fayed","year":"2016","unstructured":"Fayed E, Ahmed H. Synthesis, characterization and pharmacological evaluation of some new 1, 4-diazepine derivatives as anticancer agents. Der Pharma Chem. 2016;8:77\u201390.","journal-title":"Der Pharma Chem"},{"key":"1566_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.136663","volume":"1295","author":"EA Fayed","year":"2024","unstructured":"Fayed EA, Ebrahim MA, Fathy U, Elawady AM, Khalaf WS, Ramsis TM. Pyrano-coumarin hybrids as potential antimicrobial agents against MRSA strains: design, synthesis, ADMET, molecular docking studies, as DNA gyrase inhibitors. J Mol Struct. 2024;1295: 136663.","journal-title":"J Mol Struct"},{"issue":"11","key":"1566_CR28","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00044-023-03148-1","volume":"32","author":"TM Ramsis","year":"2023","unstructured":"Ramsis TM, Ebrahim MA, Fayed EA. Synthetic coumarin derivatives with anticoagulation and antiplatelet aggregation inhibitory effects. Med Chem Res. 2023;32(11):2269\u201378.","journal-title":"Med Chem Res"},{"issue":"4","key":"1566_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/157018011794839448","volume":"8","author":"B AbdelFattah","year":"2011","unstructured":"AbdelFattah B, Khalifa M, El-Sehrawi H, Fayed E, Bayoumi A, Said M. Synthesis and anxiolytic activity of some novel 5-oxo-1, 4-oxazepine derivatives. Lett Drug Design Discov. 2011;8(4):330\u20138.","journal-title":"Lett Drug Design Discov."},{"key":"1566_CR30","first-page":"269","volume":"33","author":"B Abdel Fattah","year":"2010","unstructured":"Abdel Fattah B, Khalifa M, El-Sehraswi H, Fayed E, Bayoumi A, Said M. Synthesis, anxiolytic and antimicrobial activity of some novel 5-oxo-1, 4-oxazepine derivatives. J Egypt Biomed Sci. 2010;33:269.","journal-title":"J Egypt Biomed Sci"},{"issue":"2","key":"1566_CR31","first-page":"2017","volume":"7","author":"B Mousa","year":"2017","unstructured":"Mousa B, Khalifa M, Fayed E, Said M, Ahmed H. Synthesis, anxiolytic and tranquilizing activity of some new 1, 4-diazepine derivatives. Am J PharmTech Res. 2017;7(2):2017.","journal-title":"Am J PharmTech Res"},{"issue":"1","key":"1566_CR32","doi-asserted-by":"publisher","first-page":"e23189","DOI":"10.1016\/j.heliyon.2023.e23189","volume":"10","author":"U Fathy","year":"2024","unstructured":"Fathy U, Abd El Salam HA, Fayed EA, Elgamal AM, Gouda A. Erratum to \u201cFacile synthesis and in vitro anticancer evaluation of a new series of tetrahydroquinoline\u201d [Heliyon 7(10) (October 2021) e08117]. Heliyon. 2024;10(1):e23189.","journal-title":"Heliyon."},{"key":"1566_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jmgm.2015.06.006","volume":"60","author":"F Aksakal","year":"2015","unstructured":"Aksakal F, Shvets N, Dimoglo A. The study of dual COX-2\/5-LOX inhibitors by using electronic-topological approach based on data on the ligand\u2013receptor interactions. J Mol Graph Model. 2015;60:79\u201388.","journal-title":"J Mol Graph Model"},{"issue":"1","key":"1566_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1472-8206.2003.00217.x","volume":"18","author":"B Bannwarth","year":"2004","unstructured":"Bannwarth B. Is licofelone, a dual inhibitor of cyclo-oxygenase and 5-lipoxygenase, a promising alternative in anti-inflammatory therapy? Fundam Clin Pharmacol. 2004;18(1):125\u201330.","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"1566_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"A Rakita","year":"2020","unstructured":"Rakita A, Nikoli\u0107 N, Mildner M, Matiasek J, Elbe-B\u00fcrger A. Re-epithelialization and immune cell behaviour in an ex vivo human skin model. Sci Rep. 2020;10(1):1.","journal-title":"Sci Rep"},{"issue":"1","key":"1566_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1039\/D4MD00471J","volume":"16","author":"P Saraf","year":"2025","unstructured":"Saraf P, Bhardwaj B, Verma A, Siddiqui MA, Verma H, Kumar P, et al. Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2\/5-LOX inhibitors with anti-inflammatory and anti-cancer activity. RSC Med Chem. 2025;16(1):200\u201320.","journal-title":"RSC Med Chem"},{"issue":"1","key":"1566_CR37","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1038\/s41598-023-35161-0","volume":"13","author":"M Rudrapal","year":"2023","unstructured":"Rudrapal M, Eltayeb WA, Rakshit G, El-Arabey AA, Khan J, Aldosari SM, et al. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies. Sci Rep. 2023;13(1):8656.","journal-title":"Sci Rep"},{"issue":"2","key":"1566_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/scipharm89020022","volume":"89","author":"M Mishchenko","year":"2021","unstructured":"Mishchenko M, Shtrygol S, Lozynskyi A, Khomyak S, Novikov V, Karpenko O, et al. Evaluation of anticonvulsant activity of dual COX-2\/5-LOX inhibitor darbufelon and its novel analogues. Sci Pharm. 2021;89(2):22.","journal-title":"Sci Pharm"},{"issue":"4","key":"1566_CR39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1742-1241.2007.01320.x","volume":"61","author":"W Berger","year":"2007","unstructured":"Berger W, De Chandt MTM, Cairns CB. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease. Int J Clin Pract. 2007;61(4):663\u201376.","journal-title":"Int J Clin Pract"},{"issue":"9","key":"1566_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/abbs\/gmt064","volume":"45","author":"K Bishayee","year":"2013","unstructured":"Bishayee K, Khuda-Bukhsh AR. 5-Lipoxygenase Antagonist therapy: a new approach towards targeted cancer chemotherapy. Acta Biochim Biophys Sin. 2013;45(9):709\u201319.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"6","key":"1566_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/ph16060848","volume":"16","author":"HH Arab","year":"2023","unstructured":"Arab HH, Khames A, Mohammad MK, Alsufyani SE, Ashour AM, El-Sheikh AAK, et al. Meloxicam targets COX-2\/NOX1\/NOX4\/Nrf2 axis to ameliorate the depression-like neuropathology induced by chronic restraint stress in rats. Pharmaceuticals. 2023;16(6):848.","journal-title":"Pharmaceuticals"},{"issue":"132","key":"1566_CR42","first-page":"1241","volume":"65","author":"U Fathy","year":"2022","unstructured":"Fathy U, Yousif MNM, Mohi El-Deen EM, Fayed E. Design, synthesis, and biological evaluation of a novel series of thiazole derivatives based on pyrazoline as anticancer agents. Egypt J Chem. 2022;65(132):1241\u201352.","journal-title":"Egypt J Chem"},{"key":"1566_CR43","doi-asserted-by":"crossref","unstructured":"Taylor R. The hydrogen bond between N-H or O-H and organic fluorine: favourable yes, competitive no. Acta crystallographica Section B, Structural science, crystal engineering and materials. 2017;73(Pt 3):474-88.","DOI":"10.1107\/S2052520617005923"},{"issue":"25","key":"1566_CR44","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1002\/chem.201604632","volume":"23","author":"F Scheidt","year":"2017","unstructured":"Scheidt F, Selter P, Santschi N, Holland MC, Dudenko DV, Daniliuc C, et al. Emulating natural product conformation by cooperative, non-covalent fluorine interactions. Chemistry. 2017;23(25):6142\u20139.","journal-title":"Chemistry"},{"issue":"12","key":"1566_CR45","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3184\/174751916X14798125870610","volume":"40","author":"S ElKalyoubi","year":"2016","unstructured":"ElKalyoubi S, Fayed E. Synthesis and evaluation of antitumour activities of novel fused tri- and tetracyclic uracil derivatives. J Chem Res. 2016;40(12):771\u20137.","journal-title":"J Chem Res"},{"issue":"1","key":"1566_CR46","doi-asserted-by":"publisher","first-page":"2367128","DOI":"10.1080\/14756366.2024.2367128","volume":"39","author":"NA Gohar","year":"2024","unstructured":"Gohar NA, Fayed EA, Ammar Y, Abu Ali O, Ragab A, Mahfoz AM, et al. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting \u03b1-amylase, and \u03b1-glucosidase: synthesis, molecular docking, and ADMET studies. J Enzyme Inhibition Med Chem. 2024;39(1):2367128.","journal-title":"J Enzyme Inhibition Med Chem."},{"issue":"5","key":"1566_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/cbic.200301023","volume":"5","author":"H-J B\u00f6hm","year":"2004","unstructured":"B\u00f6hm H-J, Banner D, Bendels S, Kansy M, Kuhn B, M\u00fcller K, et al. Fluorine in medicinal chemistry. ChemBioChem. 2004;5(5):637\u201343.","journal-title":"ChemBioChem"},{"issue":"10","key":"1566_CR48","doi-asserted-by":"publisher","first-page":"e08117","DOI":"10.1016\/j.heliyon.2021.e08117","volume":"7","author":"U Fathy","year":"2021","unstructured":"Fathy U, Abd El Salam HA, Fayed EA, Elgamal AM, Gouda A. Facile synthesis and in vitro anticancer evaluation of a new series of tetrahydroquinoline. Heliyon. 2021;7(10):e08117.","journal-title":"Heliyon."},{"issue":"8","key":"1566_CR49","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1021\/acs.chemrev.0c01263","volume":"121","author":"J Han","year":"2021","unstructured":"Han J, Kiss L, Mei H, Remete AM, Ponikvar-Svet M, Sedgwick DM, et al. Chemical aspects of human and environmental overload with fluorine. Chem Rev. 2021;121(8):4678\u2013742.","journal-title":"Chem Rev"},{"key":"1566_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108023","volume":"154","author":"MS Abusaif","year":"2025","unstructured":"Abusaif MS, Ragab A, Fayed EA, Ammar YA, Gowifel AMH, Hassanin SO, et al. Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2\/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulation. Bioorg Chem. 2025;154: 108023.","journal-title":"Bioorg Chem"},{"issue":"1","key":"1566_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13065-017-0302-4","volume":"11","author":"SA El-Kalyoubi","year":"2017","unstructured":"El-Kalyoubi SA, Fayed EA, Abdel-Razek AS. Erratum to: one pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. Chem Cent J. 2017;11(1):69.","journal-title":"Chem Cent J"},{"issue":"5","key":"1566_CR52","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14756360701425014","volume":"22","author":"P Shah","year":"2007","unstructured":"Shah P, Westwell AD. The role of fluorine in medicinal chemistry. J Enzyme Inhib Med Chem. 2007;22(5):527\u201340.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"1566_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00044-022-03004-8","volume":"32","author":"EA Fayed","year":"2023","unstructured":"Fayed EA, Gohar NA, Bayoumi AH, Ammar YA. Novel fluorinated pyrazole-based heterocycles scaffold: cytotoxicity, in silico studies and molecular modelling targeting double mutant EGFR L858R\/T790M as antiproliferative and apoptotic agents. Med Chem Res. 2023;32(2):369\u201388.","journal-title":"Med Chem Res"},{"key":"1566_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137374","volume":"1301","author":"EA Fayed","year":"2024","unstructured":"Fayed EA, Thabet A, El-Gilil SMA, Elsanhory HMA, Ammar YA. Fluorinated thiazole\u2013thiosemicarbazones hybrids as potential PPAR-\u03b3 agonist and \u03b1-amylase, \u03b1-glucosidase antagonists: design, synthesis, in silico ADMET and docking studies and hypoglycemic evaluation. J Mol Struct. 2024;1301: 137374.","journal-title":"J Mol Struct"},{"issue":"7","key":"1566_CR55","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1021\/jm401375q","volume":"57","author":"EA Ilardi","year":"2014","unstructured":"Ilardi EA, Vitaku E, Njardarson JT. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery. J Med Chem. 2014;57(7):2832\u201342.","journal-title":"J Med Chem"},{"key":"1566_CR56","first-page":"369","volume-title":"Annual reports in medicinal chemistry","author":"CECA Hop","year":"2006","unstructured":"Hop CECA, Kalgutkar AS, Soglia JR. Importance of early assessment of bioactivation in drug discovery. In: Wood A, editor. Annual reports in medicinal chemistry, vol. 41. Academic Press; 2006. p. 369\u201381."},{"issue":"4","key":"1566_CR57","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/cr4002879","volume":"114","author":"J Wang","year":"2014","unstructured":"Wang J, S\u00e1nchez-Rosell\u00f3 M, Ace\u00f1a JL, del Pozo C, Sorochinsky AE, Fustero S, et al. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001\u20132011). Chem Rev. 2014;114(4):2432\u2013506.","journal-title":"Chem Rev"},{"issue":"12","key":"1566_CR58","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1021\/acs.jcim.0c00898","volume":"60","author":"A Abula","year":"2020","unstructured":"Abula A, Xu Z, Zhu Z, Peng C, Chen Z, Zhu W, et al. Substitution effect of the trifluoromethyl group on the bioactivity in medicinal chemistry: statistical analysis and energy calculations. J Chem Inf Model. 2020;60(12):6242\u201350.","journal-title":"J Chem Inf Model"},{"key":"1566_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101706","volume":"10","author":"S Arif","year":"2024","unstructured":"Arif S, Khan S, Iqbal T, Yallur BC, Rahim F, Hussain R, et al. Synthesis, characterization, DFT, AMDET and molecular docking reveals the binding mechanism of hydroxyl containing bis-Schiff base derivatives: an approach toward Alzheimer disease. Results Chem. 2024;10: 101706.","journal-title":"Results Chem"},{"issue":"7","key":"1566_CR60","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2174\/1568026614666140202210016","volume":"14","author":"G Landelle","year":"2014","unstructured":"Landelle G, Panossian A, Leroux F. Trifluoromethyl ethers and & #8211;thioethers as tools for medicinal chemistry and drug discovery. Curr Topics Med Chem. 2014;14(7):941\u201351.","journal-title":"Curr Topics Med Chem."},{"issue":"16","key":"1566_CR61","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.1021\/acs.jmedchem.5b00494","volume":"58","author":"J Liu","year":"2015","unstructured":"Liu J, Pham PT, Skripnikova EV, Zheng S, Lovings LJ, Wang Y, et al. A ligand-based drug design discovery of 4-trifluoromethyl-7,8-pyranocoumarin as a selective inhibitor of human cytochrome P450 1A2. J Med Chem. 2015;58(16):6481\u201393.","journal-title":"J Med Chem"},{"issue":"11","key":"1566_CR62","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/pharmaceutics14112538","volume":"14","author":"D Benedetto Tiz","year":"2022","unstructured":"Benedetto Tiz D, Bagnoli L, Rosati O, Marini F, Santi C, Sancineto L. FDA-approved small molecules in 2022: clinical uses and their synthesis. Pharmaceutics. 2022;14(11):2538.","journal-title":"Pharmaceutics"},{"issue":"19","key":"1566_CR63","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.3390\/molecules26196057","volume":"26","author":"SB Christensen","year":"2021","unstructured":"Christensen SB. Drugs that changed society: history and current status of the early antibiotics: salvarsan, sulfonamides, and \u03b2-lactams. Molecules. 2021;26(19):6057.","journal-title":"Molecules"},{"issue":"2","key":"1566_CR64","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","volume":"13","author":"A Ovung","year":"2021","unstructured":"Ovung A, Bhattacharyya J. Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophys Rev. 2021;13(2):259\u201372.","journal-title":"Biophys Rev"},{"key":"1566_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103878","volume":"100","author":"TS Ibrahim","year":"2020","unstructured":"Ibrahim TS, Salem IM, Mostafa SM, El-Sabbagh OI, ElKhamisi MKM, Hegazy L, et al. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold. Bioorg Chem. 2020;100: 103878.","journal-title":"Bioorg Chem"},{"issue":"11","key":"1566_CR66","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2174\/138527212800672664","volume":"16","author":"S Dadiboyena","year":"2012","unstructured":"Dadiboyena S, Hamme A II. Synthesis of celecoxib and structural analogs- a review. Curr Org Chem. 2012;16(11):1390\u2013407.","journal-title":"Curr Org Chem"},{"issue":"18","key":"1566_CR67","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1021\/jm010153c","volume":"44","author":"AG Habeeb","year":"2001","unstructured":"Habeeb AG, Praveen Rao PN, Knaus EE. Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere. J Med Chem. 2001;44(18):3039\u201342.","journal-title":"J Med Chem"},{"issue":"20","key":"1566_CR68","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1021\/jm040782x","volume":"47","author":"L Di Nunno","year":"2004","unstructured":"Di Nunno L, Vitale P, Scilimati A, Tacconelli S, Patrignani P. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal. J Med Chem. 2004;47(20):4881\u201390.","journal-title":"J Med Chem"},{"issue":"13","key":"1566_CR69","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2165\/00003495-200565130-00008","volume":"65","author":"GL Plosker","year":"2005","unstructured":"Plosker GL, Croom KF. Sulfasalazine. Drugs. 2005;65(13):1825\u201349.","journal-title":"Drugs"},{"issue":"2","key":"1566_CR70","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10067-014-2769-x","volume":"35","author":"PA MacMullan","year":"2016","unstructured":"MacMullan PA, Madigan AM, Paul N, Peace AJ, Alagha A, Nolan KB, et al. Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis. Clin Rheumatol. 2016;35(2):447\u201355.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"1566_CR71","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/iub.1334","volume":"66","author":"S Xu","year":"2014","unstructured":"Xu S, Rouzer CA, Marnett LJ. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life. 2014;66(12):803\u201311.","journal-title":"IUBMB Life"},{"issue":"24","key":"1566_CR72","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.2174\/0929867322666150716113501","volume":"22","author":"C De Monte","year":"2015","unstructured":"De Monte C, Carradori S, Gentili A, Mollica A, Trisciuoglio D, Supuran C. Dual cyclooxygenase and carbonic anhydrase inhibition by nonsteroidal anti-inflammatory drugs for the treatment of cancer. Curr Med Chem. 2015;22(24):2812\u20138.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1566_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-014-0225-9","volume":"23","author":"W Asghar","year":"2015","unstructured":"Asghar W, Jamali F. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. Inflammopharmacology. 2015;23(1):1\u201316.","journal-title":"Inflammopharmacology"},{"key":"1566_CR74","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2147\/JIR.S286110","volume":"13","author":"NS Yarla","year":"2020","unstructured":"Yarla NS, Pathuri G, Gali H, Terzyan S, Panneerselvam J, Chandrakesan P, et al. Discovery and development of a novel mPGES-1\/5-LOX dual inhibitor LFA-9 for prevention and treatment of chronic inflammatory diseases. J Inflamm Res. 2020;13:1261\u201378.","journal-title":"J Inflamm Res"},{"issue":"3","key":"1566_CR75","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1089\/jmf.2008.0133","volume":"12","author":"B Roschek","year":"2009","unstructured":"Roschek B, Fink RC, Li D, McMichael M, Tower CM, Smith RD, et al. Pro-inflammatory enzymes, cyclooxygenase 1, cyclooxygenase 2, and 5-lipooxygenase, inhibited by stabilized rice bran extracts. J Med Food. 2009;12(3):615\u201323.","journal-title":"J Med Food"},{"issue":"6","key":"1566_CR76","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/molecules27061994","volume":"27","author":"MS Refaey","year":"2022","unstructured":"Refaey MS, Abouelela ME, El-Shoura EAM, Alkhalidi HM, Fadil SA, Elhady SS, et al. In vitro anti-inflammatory activity of cotula anthemoides essential oil and in silico molecular docking of its bioactives. Molecules. 2022;27(6):1994.","journal-title":"Molecules"},{"issue":"7","key":"1566_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131813","volume":"10","author":"K-S Cho","year":"2015","unstructured":"Cho K-S, Lee J-H, Park M-K, Park H-K, Yu H-S, Roh H-J. Prostaglandin E2 and transforming growth factor-\u03b2 play a critical role in suppression of allergic airway inflammation by adipose-derived stem cells. PLoS ONE. 2015;10(7): e0131813.","journal-title":"PLoS ONE"},{"issue":"10","key":"1566_CR78","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1248\/bpb.26.1424","volume":"26","author":"R Govindarajan","year":"2003","unstructured":"Govindarajan R, Rastogi S, Vijayakumar M, Shirwaikar A, Rawat AKS, Mehrotra S, et al. Studies on the Antioxidant Activities of Desmodium gangeticum. Biol Pharm Bull. 2003;26(10):1424\u20137.","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"1566_CR79","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jphp.12421","volume":"67","author":"D Hwang","year":"2015","unstructured":"Hwang D, Son B-W, Shin P-G, Choi J-S, Seo Y-B, Kim G-D. Toluhydroquinone from Aspergillus sp. suppress inflammatory mediators via nuclear factor-\u03baB and mitogen-activated protein kinases pathways in lipopolysaccharide-induced RAW264.7 cells. J Pharm Pharmacol. 2015;67(9):1297\u2013305.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"1566_CR80","doi-asserted-by":"publisher","first-page":"2100454","DOI":"10.1002\/ardp.202100454","volume":"355","author":"EA Fayed","year":"2022","unstructured":"Fayed EA, Gohar NA, Farrag AM, Ammar YA. Upregulation of BAX and caspase-3, as well as downregulation of Bcl-2 during treatment with indeno[1,2-b]quinoxalin derivatives, mediated apoptosis in human cancer cells. Arch Pharm. 2022;355(5):2100454.","journal-title":"Arch Pharm"},{"issue":"6","key":"1566_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2023.104773","volume":"16","author":"R Hussain","year":"2023","unstructured":"Hussain R, Rehman W, Rahim F, Khan S, Alanazi AS, Alanazi MM, et al. Synthesis, in vitro thymidine phosphorylase inhibitory activity and molecular docking study of novel pyridine-derived bis-oxadiazole bearing bis-schiff base derivatives. Arab J Chem. 2023;16(6): 104773.","journal-title":"Arab J Chem"},{"issue":"9","key":"1566_CR82","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u201372.","journal-title":"J Med Chem"},{"issue":"W1","key":"1566_CR83","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"1566_CR84","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem. 2012;55(22):10282\u20136.","journal-title":"J Med Chem"},{"issue":"3","key":"1566_CR85","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, et al. Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase. Biochem J. 2013;453(3):393\u20139.","journal-title":"Biochem J"},{"key":"1566_CR86","unstructured":"Molecular Operating Environment (MOE), 2014.09 Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2014."},{"issue":"12","key":"1566_CR87","first-page":"171","volume":"12","author":"EA Fayed","year":"2014","unstructured":"Fayed EA, Shawer TZ. Synthesis, docking and anticancer activity of some new thienopyrimidine and thienooxazine derivatives. J Nat Sci. 2014;12(12):171\u201381.","journal-title":"J Nat Sci"},{"issue":"1","key":"1566_CR88","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13568-023-01633-9","volume":"13","author":"MY Refai","year":"2023","unstructured":"Refai MY, Elazzazy AM, Desouky SE, Abu-Elghait M, Fayed EA, Alajel SM, et al. Interception of Epoxide ring to quorum sensing system in Enterococcus faecalis and Staphylococcus aureus. AMB Express. 2023;13(1):126.","journal-title":"AMB Express"},{"issue":"3","key":"1566_CR89","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/metabo12030246","volume":"12","author":"SE Desouky","year":"2022","unstructured":"Desouky SE, Abu-Elghait M, Fayed EA, Selim S, Yousuf B, Igarashi Y, et al. Secondary metabolites of actinomycetales as potent quorum sensing inhibitors targeting gram-positive pathogens: in vitro and in silico study. Metabolites. 2022;12(3):246.","journal-title":"Metabolites"},{"issue":"12","key":"1566_CR90","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1007\/s11164-017-3019-z","volume":"43","author":"YA Ammar","year":"2017","unstructured":"Ammar YA, Fayed EA, Bayoumi AH, Ezz RR, Alsaid MS, Soliman AM, et al. New chalcones bearing isatin scaffold: synthesis, molecular modeling and biological evaluation as anticancer agents. Res Chem Intermed. 2017;43(12):6765\u201386.","journal-title":"Res Chem Intermed"},{"issue":"1","key":"1566_CR91","first-page":"49","volume":"22","author":"A Ali","year":"1995","unstructured":"Ali A, Fayed E, Basha H, Hassan A. Response of peanut to some agricultural practices II-Influence of sowing dates and the application of phosphorus and gypsum on yield and yield attributes of peanut plants. Zagazig J Agric Res. 1995;22(1):49.","journal-title":"Zagazig J Agric Res"},{"key":"1566_CR92","doi-asserted-by":"crossref","unstructured":"Elseedy HA, Kiriacos C, Ramsis TM. Molecular modeling and drug development. Applied Biotechnology and Bioinformatics2024. p. 109\u201337.","DOI":"10.1002\/9781119896869.ch5"},{"key":"1566_CR93","doi-asserted-by":"publisher","first-page":"108218","DOI":"10.1016\/j.bioorg.2025.108218","volume":"156","author":"MA Ebrahim","year":"2025","unstructured":"Ebrahim MA, Ramsis TM, Gohar NA, Metwally SA, Rushdi A, Fayed EA. Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoprotein. Bioorg Chem. 2025;156:108218.","journal-title":"Bioorg Chem"},{"key":"1566_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117201","volume":"284","author":"EA Fayed","year":"2025","unstructured":"Fayed EA, El-Sebaey SA, Ebrahim MA, Abu-Elfotuh K, El-Sayed Mansour R, Mohamed EK, et al. Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-Vivo and in-Vitro assays, ADMET and molecular docking simulation. Eur J Med Chem. 2025;284: 117201.","journal-title":"Eur J Med Chem"},{"issue":"7","key":"1566_CR95","doi-asserted-by":"publisher","first-page":"1800017","DOI":"10.1002\/ardp.201800017","volume":"351","author":"TM Ramsis","year":"2018","unstructured":"Ramsis TM, Abdel Karim SE, Vassilaki N, Frakolaki E, Kamal AAM, Zoidis G, et al. Expanding the chemical space of anti-HCV NS5A inhibitors by stereochemical exchange and peptidomimetic approaches. Arch Pharm. 2018;351(7):1800017.","journal-title":"Arch Pharm"},{"key":"1566_CR96","doi-asserted-by":"crossref","unstructured":"Korkor AM, Abbass HS, Ahmed AH, Mansour AM, Ramsis TM, Elkousy RH, et al. Insulinotropic and anti-obesity properties of ethno-medicinal plants: pharmacology-based and in-silico predictions. Nat Prod Res. 2025:1\u201310.","DOI":"10.1080\/14786419.2025.2457603"},{"issue":"11","key":"1566_CR97","first-page":"6439","volume":"64","author":"HM Anwar","year":"2021","unstructured":"Anwar HM, Georgy GS, Hassan AA, Gad AM. Honokiol mitigates gastric ulcer induced by indomethacin in rats via suppression of inflammatory biomarkers and reactive oxygen species. Egypt J Chem. 2021;64(11):6439\u201347.","journal-title":"Egypt J Chem"},{"key":"1566_CR98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cbi.2019.05.029","volume":"308","author":"AM Badawy","year":"2019","unstructured":"Badawy AM, El-Naga RN, Gad AM, Tadros MG, Fawzy HM. Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-\u03b3, inflammation, apoptosis and Wnt\/\u03b2-catenin pathway. Chem Biol Interact. 2019;308:137\u201346.","journal-title":"Chem Biol Interact"},{"issue":"10","key":"1566_CR99","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/jbt.21587","volume":"28","author":"AM El-Garhy","year":"2014","unstructured":"El-Garhy AM, Abd El-Raouf OM, El-Sayeh BM, Fawzy HM, Abdallah DM. Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats. J Biochem Mol Toxicol. 2014;28(10):472\u20139.","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"1566_CR100","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s10753-018-0841-4","volume":"41","author":"KM Kamel","year":"2018","unstructured":"Kamel KM, Gad AM, Mansour SM, Safar MM, Fawzy HM. Novel anti-arthritic mechanisms of polydatin in complete Freund\u2019s adjuvant-induced arthritis in rats: involvement of IL-6, STAT-3, IL-17, and NF-\u043aB. Inflammation. 2018;41(5):1974\u201386.","journal-title":"Inflammation"},{"issue":"4","key":"1566_CR101","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"D Wardyn Joanna","year":"2015","unstructured":"Wardyn Joanna D, Ponsford Amy H, Sanderson CM. Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans. 2015;43(4):621\u20136.","journal-title":"Biochem Soc Trans"},{"key":"1566_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809952","volume":"9","author":"W Gao","year":"2021","unstructured":"Gao W, Guo L, Yang Y, Wang Y, Xia S, Gong H, et al. Dissecting the crosstalk between Nrf2 and NF-\u03baB response pathways in drug-induced toxicity. Front Cell Dev Biol. 2021;9: 809952.","journal-title":"Front Cell Dev Biol"},{"key":"1566_CR103","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.biopha.2018.12.112","volume":"111","author":"HAS Alhaithloul","year":"2019","unstructured":"Alhaithloul HAS, Alotaibi MF, Bin-Jumah M, Elgebaly H, Mahmoud AM. Olea europaea leaf extract up-regulates Nrf2\/ARE\/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress, inflammation and apoptosis in rat kidney. Biomed Pharmacother. 2019;111:676\u201385.","journal-title":"Biomed Pharmacother"},{"key":"1566_CR104","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.biopha.2017.07.101","volume":"94","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud AM, Hozayen WG, Ramadan SM. Berberine ameliorates methotrexate-induced liver injury by activating Nrf2\/HO-1 pathway and PPAR\u03b3, and suppressing oxidative stress and apoptosis in rats. Biomed Pharmacother. 2017;94:280\u201391.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1566_CR105","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-\u03baB is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008;22(11):1490\u2013500.","journal-title":"Genes Dev"},{"issue":"3","key":"1566_CR106","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H van de Waterbeemd","year":"2003","unstructured":"van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2003;2(3):192\u2013204.","journal-title":"Nat Rev Drug Discov"},{"issue":"26","key":"1566_CR107","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1021\/jm060642i","volume":"49","author":"SA Hitchcock","year":"2006","unstructured":"Hitchcock SA, Pennington LD. Structure\u2212brain exposure relationships. J Med Chem. 2006;49(26):7559\u201383.","journal-title":"J Med Chem"},{"issue":"4","key":"1566_CR108","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ejps.2013.04.024","volume":"49","author":"M Prinz","year":"2013","unstructured":"Prinz M, Parlar S, Bayraktar G, Alpt\u00fcz\u00fcn V, Erciyas E, Fallarero A, et al. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-\u03b2 aggregation crossing the blood\u2013brain barrier. Eur J Pharm Sci. 2013;49(4):603\u201313.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1566_CR109","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acs.jcim.6b00465","volume":"57","author":"SJ Capuzzi","year":"2017","unstructured":"Capuzzi SJ, Muratov EN, Tropsha A. Phantom PAINS: problems with the utility of alerts for Pan-Assay INterference CompoundS. J Chem Inf Model. 2017;57(3):417\u201327.","journal-title":"J Chem Inf Model"},{"key":"1566_CR110","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00044-019-02373-x","volume":"28","author":"EA Fayed","year":"2019","unstructured":"Fayed EA, Sabour R, Harras MF, Mehany AB. Design, synthesis, biological evaluation and molecular modeling of new coumarin derivatives as potent anticancer agents. Med Chem Res. 2019;28:1284\u201397.","journal-title":"Med Chem Res"},{"issue":"1","key":"1566_CR111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1):3\u201325.","journal-title":"Adv Drug Deliv Rev"},{"issue":"21","key":"1566_CR112","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43(21):3867\u201377.","journal-title":"J Med Chem"},{"issue":"12","key":"1566_CR113","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615\u201323.","journal-title":"J Med Chem"},{"issue":"1","key":"1566_CR114","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1999;1(1):55\u201368.","journal-title":"J Comb Chem"},{"issue":"12","key":"1566_CR115","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. J Med Chem. 2001;44(12):1841\u20136.","journal-title":"J Med Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01566-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01566-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01566-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:04:18Z","timestamp":1759489458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01566-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1566"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01566-3","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}